BioScript Solutions Appoints Chief Operating Officer
October 19, 2026 – BioScript announced the appointment of Jennifer Casu-Morin as Chief Operating Officer. In this role, Jennifer (Jen) will lead BioScript’s pharmacy and clinic operations across Canada, supporting the organization’s next phase of growth and market leadership.
She brings a proven track record of more than 30 years as a healthcare executive, most recently serving as President of National Seating & Mobility Canada, where she led the organization through a period of growth, cultural integration, and transformation. Her career has also included senior leadership roles with Bayshore Home Care Solutions, Shoppers Drug Mart, MediSystem Pharmacy and McKesson Canada. Across these organizations, Jen has led large, geographically dispersed teams and complex healthcare operations spanning home care, community pharmacy, institutional pharmacy, specialty pharmacy, and mobility solutions.
“Jen brings an impressive combination of healthcare experience, operational leadership and genuine care for people,” says Lisa Matar, Chief Executive Officer of BioScript Solutions. “She understands how to lead transformation while building trust, developing strong teams and keeping patients at the centre of the work. I am delighted to welcome Jen to BioScript and look forward to partnering with her as we continue to grow and evolve.”
“What drew me to BioScript is its patient-first purpose, entrepreneurial spirit and deep Canadian roots,” says Jen. “I am excited to listen and learn from the team members closest to our patients and our operations, and to work alongside Lisa and the leadership team as we build for the future. Growth matters, but so does preserving what makes Bioscript so special – the culture, the people, and the commitment to keep patients at the centre of every decision.”
BioScript Solutions
BioScript Solutions® is a national healthcare leader committed to helping patients with chronic illnesses achieve the best possible health outcomes by providing access to complex, specialty drug therapies and delivering full-service specialty care solutions.